Does RIFAMPIN Cause Off label use? 640 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 640 reports of Off label use have been filed in association with RIFAMPIN (Rifampin). This represents 4.8% of all adverse event reports for RIFAMPIN.
640
Reports of Off label use with RIFAMPIN
4.8%
of all RIFAMPIN reports
76
Deaths
281
Hospitalizations
How Dangerous Is Off label use From RIFAMPIN?
Of the 640 reports, 76 (11.9%) resulted in death, 281 (43.9%) required hospitalization, and 49 (7.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 640 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAMPIN Cause?
Drug ineffective (1,238)
Drug reaction with eosinophilia and systemic symptoms (1,049)
Drug interaction (735)
Pyrexia (735)
Acute kidney injury (684)
Drug-induced liver injury (684)
Condition aggravated (597)
Nausea (572)
Paradoxical drug reaction (570)
Drug resistance (539)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RIFAMPIN Alternatives Have Lower Off label use Risk?
RIFAMPIN vs RIFAMYCIN
RIFAMPIN vs RIFAPENTINE
RIFAMPIN vs RIFAXIMIN
RIFAMPIN vs RILMENIDINE
RIFAMPIN vs RILONACEPT